| By ASPEX Corporation - Pittsburgh, PA |
| Tuesday, 23 September 2008 |
 |
Following the U.S. Food and Drug Administration’s recent decision to join European and Australian authorities in the inspection of overseas drug-manufacturing facilities, the pharmaceutical industry |
|
is reexamining its approach to quality control. In response to this trend, ASPEX has announced the release of its Rx micro-analysis system, the first all-in-one tool for detecting and characterizing microscopic contaminants in pharmaceuticals.
Developed in conjunction with one of the world's leading pharmaceutical companies, the Rx represents the only integrated solution for microcontamination quality control on the production floor. Because counterfeit or contaminated drugs can result in allergic reactions or even death (as evidenced by the widely-publicized heparin epidemic), the Rx’s ability to identify harmful particles as small as 30 nanometers yields far-reaching effects for |
|
|
consumer safety. Complete with a full complement of FDA compliance features, these instruments have been successfully installed at a wide range of cGMP facilities.
“Consistent quality control is critical to the safe and successful globalization of drug production, as well as developing and implementing new analytical methodologies to support emerging 'Quality by Design' initiatives,” said Greg Ott, President at ASPEX and sponsor of the Global Pharma Manufacturing Summit, from September 22-23, in Chicago, IL.
“Unlike traditional monitoring processes that rely on laser, video, or X-ray techniques, the Rx offers increased reliability and precision by integrating a scanning electron microscope (SEM) with an energy-dispersive spectrometer (EDS) and offering a comprehensive microanalysis solution.”
About ASPEX
ASPEX is the leading provider of integrated microanalysis solutions for |
|
a wide range of critical cleanliness, microcontamination analysis, product purity, contamination diagnostics, predictive maintenance, and other process control initiatives incorporating scanning electron microscopes and elemental analysis technologies. The company’s custom solutions are at work in a variety of application-specific tasks in the steel, forensics, pharmaceutical, and automotive industries. Its full-service headquarters are located in Pittsburgh, PA.
Additional information about ASPEX and its tools for particle size analysis is located at www.aspexcorp.com
_____________________________
Want to read more?
_____________________________
Nestlé dairy products not made from milk adulterated with melamine
John McCain, Barack Obama Outline China Views Exclusively Through AmCham-China
Singapore's First Commercial Developer Of Molecular Diagnostic Assays Commences Operations
|
|
|
